Methaliq

Methadone Hydrochloride, the active ingredient in Methaliq, is an opioid analgesic presented as an oral formulation for oral use. It is employed in the management of opioid dependence and severe chronic pain in adult patients.

GNH USA supplies Methaliq as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory support and consistent product quality across multiple markets. The company adheres to stringent Good Distribution Practice standards and maintains active communication with regulatory authorities to ensure compliance and timely delivery.

Methadone Hydrochloride is used in opioid‑related disorders and severe pain management.

- Opioid dependence: stabilizes patients and reduces withdrawal symptoms during detoxification. - Maintenance therapy for opioid dependence: supports long‑term opioid substitution to prevent relapse. - Severe chronic pain: provides potent analgesia when other opioids are inadequate.

Methadone Hydrochloride may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Drowsiness: increased sedation, especially after dose initiation. - Nausea: gastrointestinal upset often early in therapy. - Dry mouth: reduced salivary flow.

Serious or Rare Side Effects: - Respiratory depression: marked reduction in breathing rate. - QT interval prolongation: risk of cardiac arrhythmia. - Severe hypotension: sudden drop in blood pressure.

When prescribing Methadone Hydrochloride, clinicians should observe several safety measures.

- Assess opioid tolerance: confirm patient’s prior exposure to opioids before initiation. - Monitor respiratory function: watch for signs of depression, especially after dose changes. - Avoid concurrent CNS depressants: limit use with benzodiazepines or alcohol. - Use caution in hepatic impairment: adjust dosing as liver function is compromised. - Educate on dependence risk: inform patients about potential for addiction and withdrawal. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Methadone Hydrochloride interacts with several drug classes that may alter its safety or efficacy.

Major Interactions (Avoid): - Benzodiazepines: combined CNS depression can cause severe respiratory depression. - MAO inhibitors: risk of hypertensive crisis and serotonin syndrome. - Strong CYP3A4 inhibitors (e.g., ketoconazole): increase methadone plasma levels.

Moderate Interactions (Monitor Closely): - CYP2B6 inducers (e.g., rifampin): may reduce methadone concentrations. - QT‑prolonging agents (e.g., certain antiarrhythmics): increase risk of cardiac arrhythmias.